Recent advances in CHO cell line development for recombinant protein production
Author:
Funder
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
National Research, Development and Innovation Office
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference74 articles.
1. The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem;Dahodwala;Curr Opin Biotechnol,2019
2. Immunogenicity of biotherapeutics: causes and association with posttranslational modifications;Kuriakose;J Immunol Res,2016
3. CHO cells in biotechnology for production of recombinant proteins: current state and further potential;Kim;Appl Microbiol Biotechnol,2012
4. Advances in Mammalian cell line development technologies for recombinant protein production;Lai;Pharmaceuticals (Basel),2013
5. Therapeutic glycoprotein production in mammalian cells;Lalonde;J Biotechnol,2017
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inefficient transcription is a production bottleneck for artificial therapeutic BiTE® proteins;New Biotechnology;2024-03
2. In pursuit of a minimal CHO genome: Establishment of large-scale genome deletions;New Biotechnology;2024-03
3. Application of the iPLUS non-coding sequence in improving biopharmaceuticals production;Frontiers in Bioengineering and Biotechnology;2024-02-06
4. Enhancing protein production and growth in chinese hamster ovary cells through miR-107 overexpression;AMB Express;2024-02-01
5. Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells;Applied Microbiology and Biotechnology;2024-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3